These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26204759)

  • 1. [Construction and identification of HSV-1 vector vaccine carrying HIV-1 antigen].
    Zhao X; Guo J; Liu X; Ma Z
    Sheng Wu Gong Cheng Xue Bao; 2015 Mar; 31(3):384-93. PubMed ID: 26204759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oncolytic property of HSV-1 recombinant viruses carrying the p53 gene].
    Wang X; Zhu H; Wang X; Liu X; Ma Z
    Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(5):370-4. PubMed ID: 26875718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.
    Saeki Y; Ichikawa T; Saeki A; Chiocca EA; Tobler K; Ackermann M; Breakefield XO; Fraefel C
    Hum Gene Ther; 1998 Dec; 9(18):2787-94. PubMed ID: 9874276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals.
    Berthomme H; Fournel S; Epstein AL
    Virology; 1996 Feb; 216(2):437-43. PubMed ID: 8607275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo.
    Tanaka M; Kagawa H; Yamanashi Y; Sata T; Kawaguchi Y
    J Virol; 2003 Jan; 77(2):1382-91. PubMed ID: 12502854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Packaging, amplification, and appraisal of the recombinant tumor-selective type I herpes simplex virus carrying GALV.fus gene.
    Bing Z; Jianru Y; Yuequan J; Shifeng C; Xinping F
    Cell Biochem Biophys; 2014 Sep; 70(1):321-6. PubMed ID: 24687598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Select Herpes Simplex Virus 1 (HSV-1) Proteins for Restriction of Human Immunodeficiency Virus Type 1 (HIV-1): HSV-1 gM Protein Potently Restricts HIV-1 by Preventing Intracellular Transport and Processing of Env gp160.
    Polpitiya Arachchige S; Henke W; Pramanik A; Kalamvoki M; Stephens EB
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles.
    Legoff J; Bouhlal H; Lecerf M; Klein C; Hocini H; Si-Mohamed A; Muggeridge M; Bélec L
    Virol J; 2007 Jan; 4():2. PubMed ID: 17207276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
    Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
    Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome.
    Meseda CA; Schmeisser F; Pedersen R; Woerner A; Weir JP
    Virology; 2004 Jan; 318(1):420-8. PubMed ID: 14972567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of HSV-1 BACs and their use for packaging of HSV-1-based amplicon vectors.
    Heister TG; Vögtlin A; Müller L; Heid I; Fraefel C
    Methods Mol Biol; 2004; 256():241-56. PubMed ID: 15024170
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of human immunodeficiency virus type 1 gag gene using genetically engineered herpes simplex virus type 1 recombinants.
    Rösen-Wolff A; Raab K; Zöller L; Darai G; Eberle J; Deinhardt F
    Virus Genes; 1990 Dec; 4(4):325-37. PubMed ID: 1962977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication-Competent Controlled Herpes Simplex Virus.
    Bloom DC; Feller J; McAnany P; Vilaboa N; Voellmy R
    J Virol; 2015 Oct; 89(20):10668-79. PubMed ID: 26269179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved safety of a replication-competent poxvirus-based HIV vaccine with the introduction of the HSV-TK/GCV suicide gene system.
    Zhang Q; Liu Z; Hou J; Wang S; Liu C; Wei M; Liu Y; Shao Y
    Vaccine; 2016 Jun; 34(30):3447-53. PubMed ID: 27195760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of the herpes simplex virus type 1 genome as a novel luciferase-tagged infectious bacterial artificial chromosome.
    Li Y; Wang S; Zhu H; Zheng C
    Arch Virol; 2011 Dec; 156(12):2267-72. PubMed ID: 21894520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel anti-herpes simplex virus type 1-specific herpes simplex virus type 1 recombinant.
    Yao F; Eriksson E
    Hum Gene Ther; 1999 Jul; 10(11):1811-8. PubMed ID: 10446921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.
    Akerblom L; Nara P; Dunlop N; Putney S; Morein B
    Biotechnol Ther; 1993; 4(3-4):145-61. PubMed ID: 8292967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
    Saydam O; Glauser DL; Fraefel C
    Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector.
    Watanabe D; Brockman MA; Ndung'u T; Mathews L; Lucas WT; Murphy CG; Felber BK; Pavlakis GN; Deluca NA; Knipe DM
    Virology; 2007 Jan; 357(2):186-98. PubMed ID: 16996101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.